These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15566317)

  • 1. Amyotrophic lateral sclerosis: contemporary concepts in etiopathogenesis and pharmacotherapy.
    Strong MJ
    Expert Opin Investig Drugs; 2004 Dec; 13(12):1593-614. PubMed ID: 15566317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
    Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astrocytes interact intimately with degenerating motor neurons in mouse amyotrophic lateral sclerosis (ALS).
    Levine JB; Kong J; Nadler M; Xu Z
    Glia; 1999 Dec; 28(3):215-24. PubMed ID: 10559780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling amyotrophic lateral sclerosis in pure human iPSc-derived motor neurons isolated by a novel FACS double selection technique.
    Toli D; Buttigieg D; Blanchard S; Lemonnier T; Lamotte d'Incamps B; Bellouze S; Baillat G; Bohl D; Haase G
    Neurobiol Dis; 2015 Oct; 82():269-280. PubMed ID: 26107889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human superoxide dismutase 1 overexpression in motor neurons of Caenorhabditis elegans causes axon guidance defect and neurodegeneration.
    Li J; Li T; Zhang X; Tang Y; Yang J; Le W
    Neurobiol Aging; 2014 Apr; 35(4):837-46. PubMed ID: 24126158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The causes and mechanism of selective motor neuron death in amyotrophic lateral sclerosis].
    Van den Bosch L
    Verh K Acad Geneeskd Belg; 2006; 68(4):249-69. PubMed ID: 17214440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
    Cervetto C; Frattaroli D; Maura G; Marcoli M
    Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress in ALS: key role in motor neuron injury and therapeutic target.
    Barber SC; Shaw PJ
    Free Radic Biol Med; 2010 Mar; 48(5):629-41. PubMed ID: 19969067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current developments in gene therapy for amyotrophic lateral sclerosis.
    Scarrott JM; Herranz-Martín S; Alrafiah AR; Shaw PJ; Azzouz M
    Expert Opin Biol Ther; 2015 Jul; 15(7):935-47. PubMed ID: 25959569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyotrophic Lateral Sclerosis: Autoimmune Pathogenic Mechanisms, Clinical Features, and Therapeutic Perspectives.
    Ralli M; Lambiase A; Artico M; de Vincentiis M; Greco A
    Isr Med Assoc J; 2019 Jul; 21(7):438-443. PubMed ID: 31507117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial dysfunction and its role in motor neuron degeneration in ALS.
    Manfredi G; Xu Z
    Mitochondrion; 2005 Apr; 5(2):77-87. PubMed ID: 16050975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase.
    Gowing G; Philips T; Van Wijmeersch B; Audet JN; Dewil M; Van Den Bosch L; Billiau AD; Robberecht W; Julien JP
    J Neurosci; 2008 Oct; 28(41):10234-44. PubMed ID: 18842883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms for neuronal degeneration in amyotrophic lateral sclerosis and in models of motor neuron death (Review).
    Martin LJ; Price AC; Kaiser A; Shaikh AY; Liu Z
    Int J Mol Med; 2000 Jan; 5(1):3-13. PubMed ID: 10601567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondria in amyotrophic lateral sclerosis: a trigger and a target.
    Dupuis L; Gonzalez de Aguilar JL; Oudart H; de Tapia M; Barbeito L; Loeffler JP
    Neurodegener Dis; 2004; 1(6):245-54. PubMed ID: 16908975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superoxide dismutase and neurofilament transgenic models of amyotrophic lateral sclerosis.
    Morrison BM; Morrison JH; Gordon JW
    J Exp Zool; 1998 Sep-Oct 1; 282(1-2):32-47. PubMed ID: 9723164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective Effect of Human Adipose Stem Cell-Derived Extract in Amyotrophic Lateral Sclerosis.
    Jeon GS; Im W; Shim YM; Lee M; Kim MJ; Hong YH; Seong SY; Kim M; Sung JJ
    Neurochem Res; 2016 Apr; 41(4):913-23. PubMed ID: 26646002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Iron in Amyotrophic Lateral Sclerosis.
    Bu XL; Xiang Y; Guo Y
    Adv Exp Med Biol; 2019; 1173():145-152. PubMed ID: 31456209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New therapeutic targets for amyotrophic lateral sclerosis.
    Kuzma-Kozakiewicz M; Kwiecinski H
    Expert Opin Ther Targets; 2011 Feb; 15(2):127-43. PubMed ID: 21133819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microglia in amyotrophic lateral sclerosis.
    Dewil M; Van Den Bosch L; Robberecht W
    Acta Neurol Belg; 2007 Sep; 107(3):63-70. PubMed ID: 18072333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.